James Schultz

Array ( [id] => 6158869 [patent_doc_number] => 20020147166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Antisense modulation of Talin expression' [patent_app_type] => new [patent_app_number] => 09/791942 [patent_app_country] => US [patent_app_date] => 2001-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23408 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147166.pdf [firstpage_image] =>[orig_patent_app_number] => 09791942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6921550 [patent_doc_number] => 20010029035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'Oligonucleotide conjugates' [patent_app_type] => new [patent_app_number] => 09/781980 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7572 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20010029035.pdf [firstpage_image] =>[orig_patent_app_number] => 09781980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779178 [patent_doc_number] => 20030050260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Method for treating diabetes by reducing in vivo cathepsin L activity' [patent_app_type] => new [patent_app_number] => 09/784641 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20102 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050260.pdf [firstpage_image] =>[orig_patent_app_number] => 09784641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7673346 [patent_doc_number] => 20040180433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods of using mammalian RNase H and compositions thereof' [patent_app_type] => new [patent_app_number] => 09/781712 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11580 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180433.pdf [firstpage_image] =>[orig_patent_app_number] => 09781712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1086153 [patent_doc_number] => 06831171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-14 [patent_title] => 'Nucleic acid catalysts with endonuclease activity' [patent_app_type] => B2 [patent_app_number] => 09/780929 [patent_app_country] => US [patent_app_date] => 2001-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23649 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/831/06831171.pdf [firstpage_image] =>[orig_patent_app_number] => 09780929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177787 [patent_doc_number] => 20020156032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Inhibition of DNA methyltransferase' [patent_app_type] => new [patent_app_number] => 09/776301 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7432 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156032.pdf [firstpage_image] =>[orig_patent_app_number] => 09776301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6115851 [patent_doc_number] => 20020174447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Method for functional mapping of an alzheimer\'s disease gene network and for identifying therapeutic agents for the treatment of alzheimer\'s disease' [patent_app_type] => new [patent_app_number] => 09/768020 [patent_app_country] => US [patent_app_date] => 2001-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16399 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0174/20020174447.pdf [firstpage_image] =>[orig_patent_app_number] => 09768020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1148689 [patent_doc_number] => 06770455 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-03 [patent_title] => 'Metal-containing ribonucleotide polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/646651 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7353 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770455.pdf [firstpage_image] =>[orig_patent_app_number] => 09646651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6880210 [patent_doc_number] => 20010031497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell' [patent_app_type] => new [patent_app_number] => 09/760417 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18795 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031497.pdf [firstpage_image] =>[orig_patent_app_number] => 09760417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1196321 [patent_doc_number] => 06727064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-27 [patent_title] => 'Antisense oligonucleotide modulation of STAT3 expression' [patent_app_type] => B2 [patent_app_number] => 09/758881 [patent_app_country] => US [patent_app_date] => 2001-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21520 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727064.pdf [firstpage_image] =>[orig_patent_app_number] => 09758881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5967925 [patent_doc_number] => 20020090614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Direct measurement method for gene expression using single chain antisense array' [patent_app_type] => new [patent_app_number] => 09/758601 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6019 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090614.pdf [firstpage_image] =>[orig_patent_app_number] => 09758601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080633 [patent_doc_number] => 20020081666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Nucleic acid enzymes for cleaving DNA' [patent_app_type] => new [patent_app_number] => 09/742966 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8830 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081666.pdf [firstpage_image] =>[orig_patent_app_number] => 09742966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851505 [patent_doc_number] => 20030143708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Method and reagent for the treatment of alzheimer\'s disease' [patent_app_type] => new [patent_app_number] => 09/745237 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 47361 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143708.pdf [firstpage_image] =>[orig_patent_app_number] => 09745237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7190264 [patent_doc_number] => 20040204373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Antisense modulation of histone deacetylase I expression' [patent_app_type] => new [patent_app_number] => 09/745167 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25494 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204373.pdf [firstpage_image] =>[orig_patent_app_number] => 09745167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761908 [patent_doc_number] => 20030125270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection' [patent_app_type] => new [patent_app_number] => 09/740332 [patent_app_country] => US [patent_app_date] => 2000-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 78581 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125270.pdf [firstpage_image] =>[orig_patent_app_number] => 09740332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056476 [patent_doc_number] => 06855700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-15 [patent_title] => 'Antisense modulation of damage-specific DNA binding protein 1, p127 expression' [patent_app_type] => utility [patent_app_number] => 09/731457 [patent_app_country] => US [patent_app_date] => 2000-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25185 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855700.pdf [firstpage_image] =>[orig_patent_app_number] => 09731457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779177 [patent_doc_number] => 20030050259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Method and reagent for the treatment of cardiac disease' [patent_app_type] => new [patent_app_number] => 09/730289 [patent_app_country] => US [patent_app_date] => 2000-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 38161 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050259.pdf [firstpage_image] =>[orig_patent_app_number] => 09730289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1340102 [patent_doc_number] => 06586180 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Directed antisense libraries' [patent_app_type] => B1 [patent_app_number] => 09/647344 [patent_app_country] => US [patent_app_date] => 2000-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 12509 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586180.pdf [firstpage_image] =>[orig_patent_app_number] => 09647344 [rel_patent_id] =>[rel_patent_doc_number] =>)